Does UPADACITINIB Cause Myocardial infarction? 448 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 448 reports of Myocardial infarction have been filed in association with UPADACITINIB (Rinvoq). This represents 0.7% of all adverse event reports for UPADACITINIB.
448
Reports of Myocardial infarction with UPADACITINIB
0.7%
of all UPADACITINIB reports
55
Deaths
219
Hospitalizations
How Dangerous Is Myocardial infarction From UPADACITINIB?
Of the 448 reports, 55 (12.3%) resulted in death, 219 (48.9%) required hospitalization, and 17 (3.8%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 448 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which UPADACITINIB Alternatives Have Lower Myocardial infarction Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL